Assembly Biosciences (ASMB) Free Cash Flow (2010 - 2026)

Assembly Biosciences' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$22.1 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 5.64% year-over-year to -$22.1 million; the TTM figure through Mar 2026 stood at -$39.8 million (up 29.13% YoY), while the FY2025 annual figure was -$41.2 million, up 19.52% from the prior year.
• Free Cash Flow was -$22.1 million for Q1 2026 at Assembly Biosciences, down from $14.2 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $73.6 million in Q4 2023 to a low of -$27.5 million in Q1 2022.
• Historically, Free Cash Flow has averaged -$10.4 million across 5 years, with a median of -$17.1 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Free Cash Flow plunged 100.55% in 2024, then soared 3592.14% in 2025.
• A 5-year view of Free Cash Flow shows it stood at -$19.3 million in 2022, then jumped by 482.13% to $73.6 million in 2023, then slumped by 100.55% to -$407000.0 in 2024, then jumped by 3592.14% to $14.2 million in 2025, then plunged by 255.6% to -$22.1 million in 2026.
• The last three Free Cash Flow figures came in at -$22.1 million (Q1 2026), $14.2 million (Q4 2025), and -$15.2 million (Q3 2025), per Business Quant data.